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Challenges and barriers to improving care of the
musculoskeletal patient of the future - a debate
article and global perspective
Hangama C Fayaz1*, Jesse B Jupiter1, Hans Christoph Pape2, R Malcolm Smith1, Peter V Giannoudis3,
Christopher G Moran4, Christian Krettek5, Karl J Prommersberger6, Michael J Raschke7 and Javad Parvizi8
Abstract
Background: With greater technological developments in the care of musculoskeletal patients, we are entering an
era of rapid change in our understanding of the pathophysiology of traumatic injury; assessment and treatment of
polytrauma and related disorders; and treatment outcomes. In developed countries, it is very likely that we will
have algorithms for the approach to many musculoskeletal disorders as we strive for the best approach with which
to evaluate treatment success. This debate article is founded on predictions of future health care needs that are
solely based on the subjective inputs and opinions of the world’s leading orthopedic surgeons.
Hence, it functions more as a forum-based rather than a scientific-based presentation. This exposé was designed to
stimulate debate about the emerging patients’ needs in the future predicted by leading orthopedic surgeons that
provide some hint as to the right direction for orthopedic care and outlines the important topics in this area.
Discussion: The authors aim to provide a general overview of orthopedic care in a typical developed country
setting. However, the regional diversity of the United States and every other industrialized nation should be
considered as a cofactor that may vary to some extent from our vision of improved orthopedic and trauma care of
the musculoskeletal patient on an interregional level.
In this forum, we will define the current and future barriers in developed countries related to musculoskeletal
trauma, total joint arthroplasty, patient safety and injuries related to military conflicts, all problems that will only
increase as populations age, become more mobile, and deal with political crisis.
Summary: It is very likely that the future will bring a more biological approach to fracture care with less invasive
surgical procedures, flexible implants, and more rapid rehabilitation methods. This international consortium
challenges the trauma and implants community to develop outcome registries that are managed through health
care offices and to prepare effectively for the many future challenges that lie in store for those who treat
musculoskeletal conditions.
Keywords: Global perspective, Future trends and needs, Algorithms of patient care, Quality assurance in Patient
care, Registries
Background
By 2020, in developed countries considerable modifica-
tion in orthopaedic care is expected to have occurred
due to changes in population demographics and innova-
tion in operative techniques, treatments, and research.
One of the most drastic changes will be due to the
aging North American population. It is predicted that,
by 2020, 16.3% of the US population and 25% of the
Canadian population will be 65 years of age or older
[1,2]. Fractures have become a leading cause of patient
morbidity and mortality in both industrialized and
developing countries. Fragility fractures represent a sub-
stantial public health problem, with more than 1.5 mil-
lion osteoporotic fragility fractures taking place each
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year in the United States. In addition, by 2020, injuries
caused by traffic accidents will represent the major
cause of fractures. Urbanization and industrialization in
China and India, which contain 40% of the world’s
population, has resulted in a clear increase in trauma-
related injuries [3].
All of these projections indicate an increased inci-
dence and prevalence of age- and traffic-related muscu-
loskeletal disabilities, such as fragility fractures,
osteoarthritis, and trauma-related injuries.
To minimize cost and increase orthopaedic care in the
future, there should be a distinct therapeutic concept
refining risk stratification, characterizing the future mus-
culoskeletal patient, and identifying at-risk patients
(Table 1).
Screening and treatment algorithm of the future
musculoskeletal patient may include the following
sequence of some diagnostic and treatment module
(modified according to Cuomo AV, Lieberman JR,
adapted from Ref #[6]) : at age 40 history, physical
examination, MRI of all joints; genetic and proteonomic
screening with microchip array; central bioinformatics
database calculates up-to-date disease risks; bioengi-
neered tissue matrix including adequate therapy con-
cept, cartilage regeneration, tissue engineering, biologic
knee replacement (meniscus replacement, articular car-
tilage paste grafting); minimally invasive implantation
of tissue matrices; physical therapy, adjusted diet, life-
style modification, work out modifications are pre-
scribed; primary care prophylaxis is initiated for
management of high risk conditions.
A lowered bone mineral density is an accurate indica-
tor of the need to begin osteoporosis treatment.
According to clinical experience, patients with osteo-
penia or osteoporosis that are informed about the
results of their bone mineral density tend take medica-
tions and be more compliant than patients who do not
know their bone mineral density results [4].
Given the potential demographic and aging changes
that await us, the creation of innovative concepts for
treating fractures is strongly needed.
Despite post-traumatic stress, depression, and the
application of antidepressive and antipsychotic medica-
tions having a major impact on patients with fractures,
one of the most neglected features of fracture healing
has been the paramount importance of post-traumatic
stress [5]. The ongoing US military experiences may
shed more light into this important aspect of treating
traumatized patients.
Screening patients for systemic risk factors (including
infection, smoking, diabetes, metabolic syndrome, Factor
XIII deficiency, soft tissue injury, and use of heparin,
non steroidal anti inflammatory drugs and cortisol) will
help to prevent and minimize risks of nonunion.
Indeed, access to information is a key element. Defin-
ing multiple risk factors enables physicians to think
ahead and prevent the occurrence of multiple musculos-
keletal injuries. By having access to detailed information
on the osteoporosis risk index, arthroplasty loosening
index and osteoarthritis risk, and considering other fac-
tors such as age, weight, and activity level, a decision
specific to each patient can be made. Gene microchip
arrays can also be considered as an option for rapid
interhospital transfer of patient data. However, the ethi-
cal aspect of this device requires more investigation [6].
As concluded by Rozental et al. (2008), a simple inter-
vention in the orthopaedic clinic significantly improves
osteoporosis screening and treatment rates. They deter-
mined that, of the two tested interventions, the one that
requires the orthopaedic surgeon to recommend a bone
mineral density examination at the time of the initial
fracture care visit resulted in an assessment rate (93%)
that was three times higher than the rate found when
this step was left to the primary care physician (30%), [4].
Microarray analysis characterizes considerable num-
bers of genes that demonstrate variable expression in
osteoblast cultures from patients with hypertrophic non-
unions compared to controls. Hoffmann et al. (2008)
indicated that cell viability, osteoblast differentiation,
and gene expression in osteoblasts are varied in patients
that tend to develop persistent and refractory fracture
nonunions. Hence, proteins included in the Wnt, insu-
lin-like growth factor 2 (IGF2), transforming growth fac-
tor beta 2 (TGF-b2), and fibroblast growth factor (FGF)
signaling pathways are of paramount importance and
can guide new ideas for clinical treatments in the future
[7]. However, screening and risk identification for
patients may initiate several conflicting dilemmas, such
as the potential for characterizing a “patient’s unique
genetic blueprint” and indicating his or her predisposi-
tion to various disorders. Such screening will cause
health, privacy, and ethical conflicts.
Because most hypertrophic nonunions might be the
result of poorly conceived and executed internal fixa-
tion, improved education and better standardization of
surgical, or non-operative, techniques might possibly be
far more effective at improving outcomes while control-
ling costs.
Algorithm of managing trauma patients - a uniform
concept
Synchronization of trauma patient assessment and man-
agement has long been an aim of trauma surgeons.
Transport between facilities, or even within facilities, is
difficult. Management is often difficult to continue, and
communication breakdown with loss of continuity of
care is typical. For seamless management to become a
reality, the trauma systems need to mature, and new
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Table 1 Diagnostic Concepts
Concept of developing treatment’s Algorithms
Osteoporosis -Idenitifcation of Patient’s phenotype
- Patient Screening
-Poor nutrition and exercise is an indicator for Osteoporosis
-Defects in collagen 1a1 and 1a2 genes
-Variations of the Wnt coreceptor; LPR5;
Osteolysis and implant loosening -Variations in the TNF gene promoter
-IL-1 gene family and related protein 3
Monitoring patients postsurgically -Urine metal ion level, serum cytokine, lymphocyte response
Mechanotransduction signaling and skeletal repair -COX2
Acute systemic inflammation and bone resorption -TNF-a, IL-6, translocation of NF-kappa-B and TNF-alpha-mRNA expression in peripheral blood monocytes
Posttraumatic stress -Trauma-focused cognitive-behavioral therapy
Cell viability, Osteoblast differentiation, gene expression of osteoblasts -Level of canonical Wnt-,IGF-, TGF-b, FGF
Concept of developing treatment’s Algorithms: Modified according to Cuomo AV, Lieberman JR (modified version, adapted from Ref #[6])
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designs for acute trauma clinical reception areas must
be developed. Appropriate regionalization of trauma
care is needed to concentrate large numbers of severely
injured patients in specialized centers with enough
volume to allow for specific building designs and provi-
sion of appropriate resources, both personnel and equip-
ment, for trauma management.
After initial field assessment, rapid transport will then
involve active online communication to the center with
coordinated monitoring of vital signs in preparation for
patient reception. To streamline patient stabilization, the
primary reception area will be staffed by surgical and
anesthetic staff who can take the patient through to
early definitive care.
As the initial assessment continues, essential radiology
and Focused Abdominal Sonogram in Trauma (FAST)
will add specificity to the early clinical diagnosis. The
integrated clinical reception area will provide the ability
to directly roll the patient into the incorporated multi-
slice X-ray computed tomography scanner (CAT) or the
integrated operating room to allow further essential
diagnostic studies or immediate control of failing vital
signs.
In patients for whom injury patterns or specific inves-
tigations indicate that direct surgical control of hemor-
rhage is impractical, incorporation of angiographic
facilities into the reception/operating suite will allow
immediate access to intravascular facilities to restore cir-
culation where practical or stop hemorrhage as needed.
The surgical team can then provide the appropriate
initial level of reconstruction before establishing critical
care support through to definitive reconstruction and
early recovery.
The ability to cool patients to limit tissue damage
from underperfusion and secondary injury will be incor-
porated throughout the entire process. This process is
sometimes practiced now and may have a specific role
in preserving neurological function and preventing the
secondary effects of shock while essential hemostasis
and reconstruction occur. In the future, this procedure
may well develop into the ability to place the severely
injured into a state of organ-preserving life suspension
while essential repairs are affected and damaged tissues
stimulated to re-grow.
The concept of such streamlined care is not unattain-
able and is developing in many centers today. Our cur-
rently applied standards already require access to
coronary angiography within a short period of time to
allow early cardiac revascularization for patients present-
ing with chest pain and ECG ST segment changes. The
new operating suite at Massachusetts General Hospital
includes rooms with an incorporated CAT scanner,
interventional angiography equipment, and an Magnetic
resonance imaging scanner (MRI).
The more basic rooms include integrated imaging,
allowing multi-screen display of extensive clinical data
including vital signs and radiographic data from all
sources. While it is interesting to speculate on the coor-
dination of these technical resources, we still believe
that the availability of experienced surgical decision-
making and interventions requiring high-level surgical
skills will remain the most critically important element
in patient care.
Despite the development of advanced tools for tech-
nology assessment and patient management, the abil-
ity to make sound surgical decisions based on basic
principles and the historical lessons of trauma surgery
will remain the most reliable resource for our
patients. Unfortunately, experience has taught us that
these lessons have to be relearned with each genera-
tion. For example, recent major disasters, such as
post-earthquake relief in Haiti and Japan, found sur-
geons from advanced centers relearning basic skills.
Such skills included basic assessment of major injury
without the use of advanced technological resources,
the value of delayed closure of traumatic amputations,
and non-operative management of many simpler
fractures.
In the future, complete diagnostics of trauma patients
should be achieved within the initial assessment. Cur-
rently, many level I trauma centers use initial computer
tomography (CT) scanning to assess the main causes of
hemorrhage. While this method appears to be accurate
for lesions of the trunk, it does not provide information
about extremity-related injuries. The patient of the
future would certainly benefit from a complete diagnos-
tic assessment, including evaluations of trunk, head,
neck, and extremity-related injuries. Ideally, this com-
plete assessment would utilize a technique that requires
limited or no radiation and generates data in a rapid
fashion.
Moreover, there should be an option to generate 3-D
images of specific areas, such as injured articular sur-
faces and/or soft tissue lesions. This technique would be
able to combine the options generated by roentgen tech-
niques and MRI.
In terms of treatment, it will remain key to stop major
bleeding immediately. Given the advantages of a damage
control concept for life-threatening injuries, alternative
techniques may be developed, including catheterization
and coiling through minimally invasive techniques.
While the minimally invasive techniques are currently
time consuming, new options my help to overcome this
obstacle. Whether these new options could be used as
part of a single approach remains to be seen. For the
definitive treatment of major blood loss, there currently
appears to be no solution other than the general techni-
ques of surgical management.
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For the repair of extremity fractures, the current mini-
mally invasive techniques may still be relevant. It is cur-
rently difficult to foresee whether alternative options
will be available. For intraoperative assessment during
the care of multiply injured patients, new diagnostic
options could provide external techniques that do not
require blood sampling and yet demonstrate the level of
blood loss, the acidity of arterial blood and the level of
inflammation. Any new method should be able to be
repeated and provide a reliable set of data. Based upon
such diagnostic procedures, surgical management can be
tapered to minimize the time in intensive care and the
hospital stay.
Total joint registry
The goal of registry studies is to assess population-based
outcomes with hospitals and implants of variable stan-
dards. According to Benson et al. and Concato et al.,
well-designed observational studies offer accurate infor-
mation on treatment effects, and thus, there will be no
need to overemphasize the role of randomized con-
trolled studies in clinical decision making [8,9].
Projections predict that the future musculoskeletal
patient population will include healthier elderly indivi-
duals, individuals with a higher average body weight,
and older individuals with better functionality. The early
diagnosis of and wider range of treatment concepts for
osteoporosis will also result in changes in the future
musculoskeletal patient population [10,11].
Trends such as increased life expectancy, the increas-
ing number of elderly patients, and the epidemic of obe-
sity will place an economic burden on total joint
arthroplasty. The eighty-five years of age and older age
group will be the most rapidly growing age group in the
population. Because the prevalence of osteoarthritis of
the hip and knee joints is associated with aging, life
expectancy and the quality of life will depend on joint
replacement surgery [12-14].
Studies addressing registry data have found that, com-
pared to an individual with a normal body mass index,
an obese individual is thirty-three times more likely to
need a total knee replacement (TKR) [15].
Projections based on data from the Nationwide Inpati-
ent Sample and other sources indicate that the number
of total hip arthroplasties will continue to increase gra-
dually, reaching around 500,000 per year in the United
States by 2030 [16].
The need for total knee arthroplasty will be much
greater [17]. Because patients will outlast their prosthe-
sis, the number of revision arthroplasties will rise
accordingly.
As Kurtz et al. indicated, the number of revision
arthroplasties has already increased by 79% over the last
decade alone. Presently, the failure rate of total hip
arthroplasty is 16.9% per year in patients older than
sixty-five years [18]. However, according to the Swedish
National Hip Arthroplasty Register, the cumulative revi-
sion rates for hip and knee arthroplasties increase with
younger age [19].
It is difficult to predict the demand for orthopaedic
services because of the potential for alternative technol-
ogies, the development of new surgical techniques, the
use of adjusted algorithms aimed at preventing disease
or injury and changes in population demographics,
which are dependent on immigration influx.
However, the most obvious fact is that there is a clear
reduction in the overall orthopaedic service capacity and
health care resources in North America and Europe and
an increase in demand for orthopaedic services.
As predicted by Kurtz et al., an increase in the need
for primary hip and knee replacement in 2030 of 174%
(from 208,600 in 2005 to 572,000 by 2030) and 673%
(from 450,000 in 2005 to 3.48 million procedures by
2030), respectively, will occur [20].
A national total joint registry will provide a mechanism
to track the longitudinal performance of specific implants
of all age groups and may lead to a decrease in the revi-
sion burden, as has been the case in Sweden [21].
The revision burden is a percentage calculated by
dividing the number of revisions done over a certain
period by the total number of primary and revision hip
replacements performed during the same time period
[21]. For example, in Sweden’s registry, the revision bur-
den for cemented prostheses from 1979 to 2000 was
7.4%, while that for uncemented implants was 17.9%.
This result supports the hesitation of Swedish surgeons
to use uncemented implants. Since 1992, parameters
such as patient’s age, sex, operated side, diagnosis,
implant (manufacturer’s catalog number), surgical
approach, and cement brand have been registered for
primary implants in the Swedish registry [21]. The addi-
tion of parameters such as functional demand, body
mass index, and physical activity may improve data
interpretation [22].
Registries are considered to be a good instrument to
improve quality in health care. However, every region
has its own population-specific outcome that cannot be
compared to other regions’ patient outcomes. The addi-
tion of information on patient outcomes, satisfaction
and radiographic information will improve the impact of
the registries worldwide.
The distinct advantage of each country having its own
total joint replacement registry is that these registries
have the potential to identify complications long before
they would be reported in conventional research-based
clinical publications. The benefits of having a national
guided registry are based on refining indications, surgi-
cal techniques, and implant choices [21].
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An accurate projection of the number of revision
arthroplasties required is needed, as these surgeries
involve greater economic resources than primary
procedures.
Julin et al. reported the results of a seven-year follow-
up study of 32,019 TKRs for primary or secondary
osteoarthritis to the Finnish Arthroplasty Register. Dur-
ing the follow-up, 909 TKRs were revised, 205 (23%)
due to infection and 704 for other reasons. These data
indicate that causes for revision other than infection
were more frequent in the 2 younger age groups (81%
and 85%) than in the older age group with patients > 65
years of age (74%, p = 0.002), [22]. Because of their
higher functional demands, young TKR patients seem to
be more likely to require revision [23]. Another group
that often undergoes revision is obese TKR patients, and
obesity is more common in younger patients compared
to older patients who undergo TKR [24,25].
Prosthesis loosening and revision are influenced by the
amount of physical activity, that is, the number of steps
taken by the patient per year “cyclic loading”, and the
participation in diverse physical activities. As indicated
by Julin et al., “it is not the time in service but the load-
ing of the prosthesis that leads to loosening.” They con-
cluded that in the short-term follow-up the relatively
young age of ≤ 55 years was accompanied with a higher
risk of revision, especially for aseptic failure. With
increasing age at the time of surgery, the prosthesis sur-
vival rates improved. In the category of 56- to 65-year-
old patients, the outcomes were better than in the
youngest age group, and outcomes were improved
further in patients over 65 years of age. These findings
need further clinical assessment [22]. Indeed, in patients
who are younger than 55 years old, TKR should only be
used in selected cases when there are no other options
available, such as Biologic Knee Replacement, i.e.,
meniscus replacement and articular cartilage paste graft-
ing, to minimize pain and dysfunction.
The National Trauma Data Bank registry that has
been available through the American College of Sur-
geons for a number of years has not been successful
because data entry has been voluntary. As one can ima-
gine, neither surgeons nor hospitals are very likely to
comply unless absolutely required. Hence, we recom-
mend that Joint Registries should not rely on voluntary
based data entry (like the planned American Joint Regis-
try) but rather that it should be managed through the
Department of Health, the payors or a similar venue as
is the case in Scandinavia.
Some countries like Australia, Canada, and the Scan-
dinavian countries have had great success with registries
so far. These registries have served the function of an
early warning system for prostheses that fail and have
functioned as a good tool for improving the quality of
health care. Hence, we advocate for a multinational,
government-based organized registry.
Peri-prosthetic fractures Registry
Peri-prosthetic fractures are considered as a “pre-term-
inal event” in the majority of patients [26]. The inci-
dence of periprosthetic fractures has more than doubled
over a decade period of time [27]. As indicated by Berry
et al. [28,29] the worldwide incidence of late peripros-
thetic femoral fractures is also increasing. Given the
increase in total joint arthroplasty, we will encounter an
epidemic of periprosthetic fractures that presents a glo-
bal issue. Thus, optimizing specific algorithms and
developing a detailed preoperative management concept
that includes specific patient’s related parameters, risk
factors are needed.
However, distinct algorithms have been developed,
there is still a tendency based on surgeon’s personal
experience whether to perform an osteosynthesis or a
revision arthroplasty. Until now there is no consensus
on defining the stability of an implant. While, some col-
leagues focus on x-rays, others prefer to open the proxi-
mal femur to assess the hold, and some others converge
on the patient’s pain history.
Hence, there is a clear need of performing more clini-
cal studies through developing a registry of peripros-
thetic fractures that may contain detailed information
on identifying patients at risk.
In 2006, the Trauma Surgery in Geriatrics group of the
German Society for Trauma Surgery established a peri-
prosthetic fracture register within the clinical priority pro-
gram (CPP) of the AO Foundation (Arbeitsgemeinschaft
der Osteosynthese Fragen) to describe the actual standard
of treatment and to provide a basis for further improve-
ment. Based on these data, a new classification system
needed to be developed that addresses the different
aspects of periprosthetic fractures. This classification con-
tains information related to the geriatric population, the
status of the prosthesis (e.g., primary or revision arthro-
plasty), loosening of the prosthesis, cemented or non-
cemented fracture location and bone stock (Table 2). The
Periprosthetic Fracture Register of the AO Foundation
contains following parameters: patient’s age, gender,
comorbidities, functional demand, body mass index, oper-
ated side, diagnosis, implants (manufacturer’s catalog
number), surgical approach, primary/revision prosthesis,
loosening of the prosthesis, cemented versus not cemen-
ted, cement brand, location, type of fracture, bone stock,
patient’s outcome and radiographic information.
Several centers retrospectively contributed their cases
to a national Periprosthetic Fracture Registry to charac-
terize the current standard of care in these complex
clinical cases. In a phase 2 (ongoing process) study, pro-
spective data acquisition will help to develop
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recommendations to the surgeon and to investigate the
outcome in terms of morbidity and mortality, including
revision rates and life quality.
Due to the complexity and the heterogeneity of the
investigated patient population, a multinational registry
seems necessary to prepare for the upcoming demo-
graphic changes.
Quality assurance in orthopaedics
Despite the nationwide implementation of standardized
patient safety protocols in the past decade, surgical
patients continue being susceptible to preventable com-
plications, including sentinel events and “never events”,
such as wrong-patient and wrong-site surgery [30,31]. A
recent American Academy of Orthopaedic Surgeons
(AAOS) survey among 5,540 academy members revealed
that 53% of all responders had observed a medical error
in the preceding 6 months, including 27 cases of wrong-
site surgery [32]. These data emphasize that our current
patient safety protocols are indeed not safe in protecting
our patients from suffering unintended and preventable
harm [33,34]. New strategies to improve patient safety
in surgery include the implementation of defined surgi-
cal safety checklists, “readbacks” to improve communi-
cation in perioperative services, and medical team
training programs [35,36].
At the foundation of any program designed to
improve patient safety in orthopaedics lies the need for
understanding the patterns and root causes of surgical
complications. This notion implies the honest and unfil-
tered reporting, followed by systematic work-up of any
reported adverse event in a standardized fashion. How-
ever, due to the widespread reluctance to report surgical
complications, patient safety in orthopaedics continues
to represent an essential “information problem”. Disclos-
ing and reporting of medical errors is compelling
beyond a doubt from a moral, ethical, and scientific per-
spective, and therefore represents a basic tenet for
improving patient safety.
Underreporting of surgical complications creates a gap
of information which may otherwise help prevent the
recurrence of a similar adverse event. We have recently
described a new Quality Assurance (QA) process in
orthopaedics, which was designed to lower the threshold
of reporting all perceived complications, “near-misses”,
and “no-harm events”, mandating a standardized peer-
review of all reported occurrences in a “real-time” fash-
ion [37]. The new QA process implanted at Denver
Health Medical Center relies on the following three
cornerstones:
1-Anonymous “real-time” reporting of any suspected
adverse occurrence, including “near miss” and “no harm”
events, by any member of the surgical team. Occurrences
are reported to an independent nurse provider in charge
of managing the adverse event database. A “no fault” pol-
icy for reporting occurrences is encouraged with strong
support from the department leadership.
2-Peer-review of each reported event at a weekly QA
conference, using a standardized case review form, in
the presence of the responsible attending surgeon and at
least two additional faculty staff members who were not
involved in the occurrence.
3-Corrective action is defined for each reviewed case,
if deemed necessary during the peer-review process.
Each closed case is prospectively entered into a depart-
mental QA database. All team members involved in the
adverse occurrence are notified about the final assess-
ment of the peer-review process.
The standardized case review form is shown in Figure 1
impressively, the median rate of reported occurrences
increased more than 6-fold from 1.7 to 11.1 per 100 surgi-
cal procedures, within 21/2 years of implementation of the
new QA process [37]. Similarly, the overall complication
rate for the entire Department of Orthopaedics at Denver
Health Medical Center increased almost 5-fold, from 1.4%
to 6.7%. These data emphasize the “double-edged sword”
aspect of reporting adverse events: The reported 5-fold
increase in complications within the department likely
Table 2 Preliminary Standard treatments based on the CPP of the AO Foundation
Fracture location
Around the Stem Distal the Stem At the tip of the Stem
A Primary
Prosthesis Osteosynthesis Osteosynthesis
B Revision
Prosthesis Osteosynthesis Osteosynthesis
C Loosened Prosthesis
Prosthesis Prosthesis Prosthesis
1 Cemented -2 non-cemented
1 Bone quality good - 2 bad
Preliminary parameters and standard of treatment that implicates the method based on the CPP of the AO Foundation that is considered as an alpha-numeric
code consisting of the letters A-C and numbers 1-3
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reflects the improved open and more honest reporting for-
mat and critical peer-review of each reported occurrence,
rather than a decreased quality of care. And here lies the
paradox: If the parameters of “reported adverse events” and
“incidence of complications” were used as a measure of
institutional quality, the facility would be penalized for its
improved surveillance and educational process. The thor-
ough reporting and peer-review of surgical errors creates a
A. Complication A. Education at QA Conference
B. "Near miss" event B. Guideline/protocol
C. "No harm" event C. To PI Committee/Peer Review
D. Death
E. Not a complication 1. Preventable
F. Not an Ortho complication
2. Potentially Preventable
3. Non-Preventable
A. Postoperative infection 4. Equivocal
B. Failure of reduction/fixation
C. Misplaced implant
A. OcurredD. Fracture-Nonunion
E. Wound healing issue
F. Failure of flap or replantation
G. Postop bleeding/hematoma
H. Vascular injury
B. Did not occurI.   Neurologic injury
J.  Medical complication
K. DVT/PE
L. Death
M. Other: ______________________
A. Unplanned return to OR
B. No harm
C. Harm
D. Death
E. Not determined
A. Communication
B. Supervision
C. Indication
D. Technique
E. Treatment concept
F. Judgment error
G. Aftercare
H. System issue
I.   Patient compliance
J.  Patient selection
K. Co-morbidities
L. Injury severity
M. No root cause evident
N. Other: ______________________
Name: PATIENT, TEST 30 Y 12/31/2008Admitted:
Ortho Team: /Ortho M&M:
MRN: FIN: Trauma #:9876543HH 12345678 1
Reported Event:
Co-Morbids:
I.      Status V.   Corrective Action
VI.  Preventability
II.     Specific Complication
VII. Disclosure
By whom? ________________________
Date: ____________________________
Time: ____________________________
Reason: _________________________(e.g. MI,
pneumonia, etc.)
III.    Patient Harm/Outcome
(Related to Complication)
Procedure Start: 02/01/2010 08:30
Procedure End: 02/01/2010 08:59
Antibiotics Start: 02/01/2010 08:00
Total Tourniquet Time: 00:22
12:00Heparin Start: 07/26/2009IV.    Contributing Root Cause
Last Heparin: 07/28/2009 17:00
COMMENTS RELATED TO PROCEDURE, ABX, HEPARIN HERE
Preventable
VI. - 1
Non-Preventable
VI. - 3
Confidential Privileged Quality Management Document,Equivocal VI. - 4
per C.R.S. § 25-3-109
Figure 1 Case peer-review form for reported adverse occurrences at the Department of Orthopaedics, Denver Health Medical Center
(modified version, adapted from Ref #[37]).
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new dilemma for the practicing orthopaedic surgeon: an
increased quality of reporting leads to an increased compli-
cation rate, thus affecting the individual surgeon’s profes-
sional track record and the respective institution’s ranking
among peers. Until legislation provides legal protection for
medical error disclosure and analysis, we continue to rely
on the limited and anecdotal reporting of medical errors
and surgical complications in the peer-reviewed biomedical
literature [38-40]. Unequivocally, legislative tort reform and
avoidance of punitive systems represent the basis required
to decrease the surgeons’ inherent reluctance to report
their own complications.
Conclusions
This article sheds light on challenges ahead that can
only be handled well by logistical preparation that
occurs years in advance.
Furthermore, emphasis is placed on developing and
improving patient safety protocols in orthopaedics, such
as by implementation of standardized quality assurance
protocols which are based on open, transparent report-
ing and peer-review of all adverse events. These chal-
lenges require that the international orthopaedic
community think more globally and act locally.
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IGF2: (insulin-like growth factor 2); TGF-β2: (transforming growth factor beta
2); FGF: (fibroblast growth factor); FAST: (Focused Abdominal Sonogram in
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(Quality Assurance); LRP5: (low-density lipoprotein receptor-related protein
5); TNF: (Tumor necrosis factor); IL1:(Interleukin 1); COX2:(Cylooxygenase 2);
NF-κB: (nuclear factor ‘kappa-light-chain-enhancer of activated B-cells); M&M:
(morbidity and mortality); DVT: (deep venous thrombosis); PE: (pulmonary
embolism); QA: (quality assurance); PI: (process improvement).
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